SEC Filing Summary: AmerisourceBergen Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation on January 11, 2005. The report addresses a news release issued on the same date regarding matters to be discussed by the company's Chief Executive Officer and Chief Financial Officer at the 23rd Annual JPMorgan Healthcare Conference in San Francisco. Note: The registrant is identified as AmerisourceBergen Corporation in this 2005 filing; the name Cencora, Inc. reflects a later corporate evolution.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a news release rather than a financial statement itself.
Material Changes
No material changes to financial results or operations are detailed within the text of this 8-K. The filing references assumptions underlying current estimates for diluted earnings per share from continuing operations for fiscal 2005, but does not quantify these estimates or compare them to prior periods.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of a presentation at the JPMorgan Healthcare Conference. The filing incorporates by reference a news release (Exhibit 99.1) which contains the specific assumptions for fiscal 2005 diluted earnings per share estimates. No specific risks, contingencies, or unusual items are described in the body of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (News Release dated January 11, 2005) for specific fiscal 2005 diluted earnings per share estimates and underlying assumptions.
- Verify the full transcript or presentation materials from the 23rd Annual JPMorgan Healthcare Conference for detailed management commentary.
- Confirm the corporate name change timeline from AmerisourceBergen Corporation to Cencora, Inc. for accurate historical data mapping.